NOSH: Diet Intervention for Hypertension: Adaptation and Dissemination to Native Communities

Sponsor
Washington State University (Other)
Overall Status
Recruiting
CT.gov ID
NCT02796313
Collaborator
Oklahoma State University (Other)
370
4
2
66.4
92.5
1.4

Study Details

Study Description

Brief Summary

We will conduct a randomized trial to test our DASH (Dietary Approaches to Stop Hypertension) based intervention in 370 adult American Indians with inadequately controlled systolic blood pressure (≥130 mmHg). Over the 5 years of the project, we will recruit and randomize 200 participants from each of 4 urban sites: two in Washington, one in Oklahoma, and one in South Dakota.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: DASH Groceries + Weekly Sessions
  • Behavioral: Groceries + Brochure
N/A

Detailed Description

All participants complete 3 data collection visits following an over-the-phone eligibility screening call (baseline, week 8, and week 12). Participants will be randomized into either the control group or the intervention group at the baseline visit.

All participants will receive 8 weekly credits for groceries and will be given equipment for monitoring their BP at home. Study staff will help participants place their grocery orders each week, and will collect readings from the home BP monitoring equipment at the same time. This data will be used to understand whether the intervention is effective for controlling BP.

All participants will be encouraged to maintain their regular levels of physical activity and receive treatment as usual from their healthcare providers.

The control group participants will receive an American Heart Association printed brochure about the health benefits of a low-salt diet. All foods will be available to purchase, including those that do not meet the DASH diet guidelines.

The intervention group participants will receive 1 hour of nutritional counseling over the phone and a personalized prescription for the low-salt DASH diet based on estimated calorie needs at baseline, followed by weekly 20-minute phone calls in weeks 1-8 to provide extra support.

The intervention group's food choices will be limited to fresh produce and a pre-determined list of other foods included in the DASH diet. During weekly phone calls, the dietitian will use a structured phone curriculum to discuss in more detail a different component of the DASH diet, followed by goal setting related to that component. Through small goal setting each week, participants will receive ongoing support to improve full adherence to the DASH diet by the end of week 8.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
370 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Diet Intervention for Hypertension: Adaptation and Dissemination to Native Communities
Actual Study Start Date :
Nov 17, 2017
Anticipated Primary Completion Date :
May 31, 2023
Anticipated Study Completion Date :
May 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group

Participants in the intervention group will receive tailored advice on adopting a low-sodium DASH diet, comprising nutritional education and ongoing guidance for purchasing heart-healthy foods, plus a weekly $35 credit for groceries.

Behavioral: DASH Groceries + Weekly Sessions
Intervention group participants will receive 1 hour of in-person nutritional counseling and a personalized prescription for the low-salt DASH diet based on estimated calorie needs at baseline, followed by weekly 20-minute phone calls in weeks 1-8 to provide extra support.

Active Comparator: Control Group

Participants in the control group will receive printed educational materials with general information about low-salt diets plus a weekly $35 credit for groceries.

Behavioral: Groceries + Brochure
Control group participants will receive a printed brochure about the health benefits of a low-salt diet. They will place an unrestricted $35 grocery order for 8 weeks.

Outcome Measures

Primary Outcome Measures

  1. Improved blood pressure [12 weeks]

    Systolic blood pressure measurements collected throughout the study.

Secondary Outcome Measures

  1. Improved urinary sodium/potassium levels [12 weeks]

    Measured by 24 hour urine samples collected at 3 time points.

  2. Improved BMI [12 weeks]

    Measured by weight and height. Waist circumference will also be measured.

  3. Improved blood lipids [12 weeks]

    Measured by cholesterol panel at 3 time points

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Participants must:
  • be at least 18 years old;

  • have had diagnosed hypertension for at least 1 year;

  • be on a stable routine of antihypertensive medications for at least 2 months OR not currently medicated, without anticipated changes for the duration of the study;

  • have systolic BP ≥ 130 mmHg at the past 2 clinic visits and at the screening call;

  • have access to regular medical care and permission from their primary care provider to participate (study staff obtain verbal permission before recruiting participants);

  • be physically and cognitively able to use the home BP monitoring device;

  • be willing and able to follow all other study procedures.

Exclusion Criteria:
People are ineligible if they:
  • experienced incident cardiovascular disease or stroke within the previous 6 months;

  • have a known diagnosis of secondary hypertension (e.g., renal artery stenosis);

  • have a recent history of high blood potassium due to certain medications that can raise potassium levels;

  • have diagnosed Stage 4 or 5 kidney disease;

  • are currently or planning to become pregnant during the course of the study;

  • are participating in another health research study involving hypertension;

  • are receiving treatment for cancer or another serious or terminal medical condition.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chickasaw Nation Health Clinic Purcell Oklahoma United States 73080
2 Avera Research Institute Rapid City South Dakota United States 57702
3 Seattle Indian Health Board Seattle Washington United States 98144
4 NATIVE Project Spokane Washington United States 99201

Sponsors and Collaborators

  • Washington State University
  • Oklahoma State University

Investigators

  • Principal Investigator: Dedra Buchwald, Washington State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dedra Buchwald, Professor, Washington State University
ClinicalTrials.gov Identifier:
NCT02796313
Other Study ID Numbers:
  • 1R01HL126578
First Posted:
Jun 10, 2016
Last Update Posted:
Jul 19, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 19, 2022